Abbott India Crecimiento futuro

Future controles de criterios 3/6

Se prevé un crecimiento anual de los beneficios y los ingresos de Abbott India de 11% y 11% por año respectivamente. Se prevé que el BPA crezca en un 11% al año. Se espera que la rentabilidad financiera sea de 36.2% en 3 años.

Información clave

11.0%

Tasa de crecimiento de los beneficios

11.0%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Pharmaceuticals	17.9%
Tasa de crecimiento de los ingresos	11.0%
Rentabilidad financiera futura	36.2%
Cobertura de analistas	Good
Última actualización	18 Nov 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

There's Reason For Concern Over Abbott India Limited's (NSE:ABBOTINDIA) Price

Oct 17

Is Abbott India (NSE:ABBOTINDIA) Using Too Much Debt?

Aug 31

Abbott India (NSE:ABBOTINDIA) Has Announced That It Will Be Increasing Its Dividend To ₹410.00

Jul 13

Abbott India's (NSE:ABBOTINDIA) Upcoming Dividend Will Be Larger Than Last Year's

Jun 27

Abbott India's (NSE:ABBOTINDIA) Shareholders Will Receive A Bigger Dividend Than Last Year

Jun 13

Abbott India (NSE:ABBOTINDIA) Is Paying Out A Larger Dividend Than Last Year

May 12

Is Abbott India (NSE:ABBOTINDIA) Using Too Much Debt?

Feb 23

Abbott India Limited's (NSE:ABBOTINDIA) Business Is Yet to Catch Up With Its Share Price

Jan 07

Abbott India's (NSE:ABBOTINDIA) Upcoming Dividend Will Be Larger Than Last Year's

Jul 15

Abbott India (NSE:ABBOTINDIA) Will Pay A Larger Dividend Than Last Year At ₹325.00

Jul 01

Abbott India (NSE:ABBOTINDIA) Has Announced That It Will Be Increasing Its Dividend To ₹325.00

May 22

With EPS Growth And More, Abbott India (NSE:ABBOTINDIA) Makes An Interesting Case

Apr 14

How Does Abbott India Limited (NSE:ABBOTINDIA) Stand Up To These Simple Dividend Safety Checks?

Mar 24

The Abbott India (NSE:ABBOTINDIA) Share Price Is Up 197% And Shareholders Are Boasting About It

Mar 03

Is Weakness In Abbott India Limited (NSE:ABBOTINDIA) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Feb 04

How Much Of Abbott India Limited (NSE:ABBOTINDIA) Do Institutions Own?

Jan 14

Abbott India Limited (NSE:ABBOTINDIA) Is An Attractive Dividend Stock - Here's Why

Dec 24

Announcing: Abbott India (NSE:ABBOTINDIA) Stock Increased An Energizing 185% In The Last Five Years

Dec 03

Is There More To The Story Than Abbott India's (NSE:ABBOTINDIA) Earnings Growth?

Nov 12

Previsiones de crecimiento de beneficios e ingresos

NSEI:ABBOTINDIA - Estimaciones futuras de los analistas y datos financieros pasados (INR Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
3/31/2027	79,593	16,938	16,590	16,075	4
3/31/2026	71,145	15,291	14,608	14,658	5
3/31/2025	63,842	13,788	10,692	12,345	4
9/30/2024	60,661	12,847	9,661	10,111	N/A
6/30/2024	59,275	12,390	N/A	N/A	N/A
3/31/2024	58,489	12,012	11,645	12,128	N/A
12/31/2023	57,534	11,456	N/A	N/A	N/A
9/30/2023	56,384	10,814	11,593	12,068	N/A
6/30/2023	55,236	10,340	N/A	N/A	N/A
3/31/2023	53,487	9,494	8,593	8,934	N/A
12/31/2022	52,654	9,294	N/A	N/A	N/A
9/30/2022	51,632	8,818	8,174	8,511	N/A
6/30/2022	50,058	8,086	N/A	N/A	N/A
3/31/2022	49,133	7,987	9,036	9,477	N/A
12/31/2021	47,598	7,398	N/A	N/A	N/A
9/30/2021	46,308	7,177	8,938	9,416	N/A
6/30/2021	44,636	7,061	N/A	N/A	N/A
3/31/2021	43,100	6,907	7,034	7,267	N/A
12/31/2020	41,757	6,492	N/A	N/A	N/A
9/30/2020	41,586	6,587	5,965	6,099	N/A
6/30/2020	41,585	6,563	N/A	N/A	N/A
3/31/2020	40,931	5,929	6,104	6,261	N/A
12/31/2019	40,383	5,952	N/A	N/A	N/A
9/30/2019	39,077	5,255	3,595	3,719	N/A
6/30/2019	38,326	4,849	N/A	N/A	N/A
3/31/2019	36,786	4,503	4,866	4,991	N/A
12/31/2018	35,606	4,372	N/A	N/A	N/A
9/30/2018	34,941	4,355	N/A	N/A	N/A
6/30/2018	34,460	4,354	N/A	N/A	N/A
3/31/2018	32,985	4,012	N/A	1,527	N/A
12/31/2017	32,242	3,432	N/A	N/A	N/A
9/30/2017	30,893	3,134	N/A	N/A	N/A
6/30/2017	28,794	2,509	N/A	N/A	N/A
3/31/2017	29,026	2,766	N/A	3,072	N/A
12/31/2016	28,959	2,980	N/A	N/A	N/A
9/30/2016	28,097	2,802	N/A	N/A	N/A
6/30/2016	27,293	2,663	N/A	N/A	N/A
3/31/2016	26,145	2,553	N/A	2,487	N/A
12/31/2015	25,380	2,504	N/A	N/A	N/A
9/30/2015	24,504	2,445	N/A	N/A	N/A
6/30/2015	23,950	2,466	N/A	N/A	N/A
3/31/2015	22,893	2,290	N/A	2,148	N/A
12/31/2014	22,008	2,176	N/A	N/A	N/A
9/30/2014	21,103	2,065	N/A	N/A	N/A
6/30/2014	19,776	1,880	N/A	N/A	N/A
3/31/2014	18,694	1,668	N/A	1,243	N/A
12/31/2013	17,527	1,601	N/A	N/A	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (11% al año) de ABBOTINDIA es superior a la tasa de ahorro (6.7%).

Beneficios vs. Mercado: Se prevé que los beneficios (11% al año) de ABBOTINDIA crezcan menos que el mercado Indian (17.9% al año).

Beneficios de alto crecimiento: Se prevé que los beneficios de ABBOTINDIA crezcan, pero no significativamente.

Ingresos vs. Mercado: Se prevé que los ingresos (11% al año) de ABBOTINDIA crezcan más rápidamente que los del mercado Indian (10.5% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 11% al año) de ABBOTINDIA crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de ABBOTINDIA sea alta dentro de 3 años (36.2%)

Abbott India Crecimiento futuro

Future controles de criterios 3/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Price target increased by 10% to ₹27,242

Price target increased to ₹19,998

Recent updates

Less than half of directors are independent

Second quarter 2025 earnings released: EPS: ₹169 (vs ₹147 in 2Q 2024)

Abbott India Limited Appoints Mr. Sridhar Kadangode as an Additional Director and as the Whole Time Director of the Company

Abbott India Limited to Report Q2, 2025 Results on Nov 07, 2024

There's Reason For Concern Over Abbott India Limited's (NSE:ABBOTINDIA) Price

Is Abbott India (NSE:ABBOTINDIA) Using Too Much Debt?

Abbott India Limited Approves Final Dividend for Financial Year Ended March 31, 2024

Abbott India Limited to Report Q1, 2025 Results on Aug 07, 2024

Abbott India Limited Announces Resignation of Ashok Saini - Commercial Director - GenNext, Vaccines and Neurolife, Effective October 16, 2024

Less than half of directors are independent

Full year 2024 earnings released: EPS: ₹565 (vs ₹447 in FY 2023)

Abbott India (NSE:ABBOTINDIA) Has Announced That It Will Be Increasing Its Dividend To ₹410.00

Upcoming dividend of ₹410 per share

Abbott India's (NSE:ABBOTINDIA) Upcoming Dividend Will Be Larger Than Last Year's

Abbott India's (NSE:ABBOTINDIA) Shareholders Will Receive A Bigger Dividend Than Last Year

Abbott India Limited Announces Resignation of Sabina Ewing as Director, Effective June 12, 2024

Abbott India (NSE:ABBOTINDIA) Is Paying Out A Larger Dividend Than Last Year

Abbott India Limited, Annual General Meeting, Aug 08, 2024

Full year 2024 earnings released: EPS: ₹565 (vs ₹447 in FY 2023)

Dividend increased to ₹410

Abbott India Limited Recommends Final Dividend for the Year Ended March 31, 2024, Payable on or After August 13, 2024

Abbott India Limited Recommends Final Dividend for the Year Ended March 31, 2024, Payable on or After August 13, 2024

Abbott India Limited Appoints Murari Ranganathan as Commercial Director

Less than half of directors are independent

Price target increased by 10% to ₹27,242

Abbott India Limited Announces Resignation of Sandeep Reddy - Commercial Director - Women's Health, Metabolics and International Business, with Effect from June 5, 2024

Is Abbott India (NSE:ABBOTINDIA) Using Too Much Debt?

Abbott India Limited to Report Q3, 2024 Results on Feb 01, 2024

Abbott India Limited's (NSE:ABBOTINDIA) Business Is Yet to Catch Up With Its Share Price

Abbott India Limited Announces Resignation of Vivek V Kamath as Managing Director, Effective from March 18, 2024

Second quarter 2024 earnings released: EPS: ₹147 (vs ₹125 in 2Q 2023)

Abbott India Limited to Report Q2, 2024 Results on Nov 09, 2023

Abbott India Limited Approves Appointment of Sangeeta Shetty as Company Secretary, Effective September 14, 2023

New major risk - Earnings quality

Abbott India Limited to Report Q1, 2024 Results on Aug 09, 2023

Abbott India Limited Appoints Ms Richa Tripathi as Associate Director, Effective August 3, 2023

Full year 2023 earnings released: EPS: ₹447 (vs ₹376 in FY 2022)

Abbott India's (NSE:ABBOTINDIA) Upcoming Dividend Will Be Larger Than Last Year's

Upcoming dividend of ₹325 per share at 1.4% yield

Less than half of directors are independent

Abbott India (NSE:ABBOTINDIA) Will Pay A Larger Dividend Than Last Year At ₹325.00

Abbott India (NSE:ABBOTINDIA) Has Announced That It Will Be Increasing Its Dividend To ₹325.00

Full year 2023 earnings released: EPS: ₹447 (vs ₹376 in FY 2022)

Abbott India Limited, Annual General Meeting, Aug 09, 2023

With EPS Growth And More, Abbott India (NSE:ABBOTINDIA) Makes An Interesting Case

Is Abbott India (NSE:ABBOTINDIA) Using Too Much Debt?

Third quarter 2023 earnings released: EPS: ₹116 (vs ₹93.74 in 3Q 2022)

Abbott India Limited to Report Q3, 2023 Results on Feb 10, 2023

Is Now The Time To Put Abbott India (NSE:ABBOTINDIA) On Your Watchlist?

Less than half of directors are independent

Abbott India Limited to Report Q2, 2023 Results on Nov 14, 2022

Abbott India Limited Approves Final Dividend for the Financial Year Ended March 31, 2022

Abbott India Limited to Report Q1, 2023 Results on Aug 10, 2022

Upcoming dividend of ₹275 per share

Full year 2022 earnings released: EPS: ₹376 (vs ₹325 in FY 2021)

Abbott India Limited, Annual General Meeting, Aug 10, 2022

Full year 2022 earnings released: EPS: ₹376 (vs ₹325 in FY 2021)

Abbott India Limited Recommends Special Dividend for the Year Ended March 31, 2022

Abbott India Limited to Report Q4, 2022 Results on May 17, 2022

Less than half of directors are independent

We Think Abbott India (NSE:ABBOTINDIA) Can Manage Its Debt With Ease

Less than half of directors are independent

Abbott India Limited Appoints Vivek V Kamath as Additional Director

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Abbott India Limited to Report Q3, 2022 Results on Feb 09, 2022

Here's Why We Think Abbott India (NSE:ABBOTINDIA) Is Well Worth Watching

A Look At The Intrinsic Value Of Abbott India Limited (NSE:ABBOTINDIA)

Price target increased to ₹19,998

Second quarter 2022 earnings released: EPS ₹90.51 (vs ₹85.05 in 2Q 2021)

Do Abbott India's (NSE:ABBOTINDIA) Earnings Warrant Your Attention?

Abbott India (NSE:ABBOTINDIA) Has A Rock Solid Balance Sheet

Should You Be Adding Abbott India (NSE:ABBOTINDIA) To Your Watchlist Today?

Upcoming dividend of ₹275 per share